![[111] Deprescribing Proton Pump Inhibitors](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/06/111-150x150.png)
The first PPI was approved in Canada in 1988. Pronounced and durable reduction of stomach acid production made omeprazole a “blockbuster drug”, spawning multiple imitators. Eventually this included (as patent extensions) the single enantiomers … Read More
What’s New
![[Oct 27] TI Course in Surrey: Save the Date!](https://www.ti.ubc.ca/wordpress/wp-content/themes/therapeutics-init/images/ti_ce.png)
[Oct 27] TI Course in Surrey: Save the Date!
Best Evidence for Clinicians: Annual UBC Therapeutics Initiative Course WHEN: Saturday, October 27, 2018 – full day course 08:00 - 18:00 WHERE: Surrey Memorial Hospital in Surrey, BC [map] Overview Join us for this popular … Read More
![[110] Stimulants for ADHD in children: Revisited](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/05/110-150x150.png)
[110] Stimulants for ADHD in children: Revisited
This Letter reviews our previous publications and research on this topic and explores whether our publications have led to a change in prescribing of stimulants to children in BC. Despite concerns, stimulant drug treatment of childhood … Read More
[Oct 25-26] TI Course in Nanaimo: Save the Date!
Therapeutics Initiative Conference: Using Evidence Practically - offered in collaboration with the Nanaimo Division of Family Practice WHEN: Thursday, October 25 & Friday, October 26, 2018. WHERE: Dorchester Hotel: 70 Church St, … Read More
![[109] Inhaled long acting β2 agonists for COPD](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/02/109-150x150.png)
[109] Inhaled long acting β2 agonists for COPD
In Therapeutics Letter #1021 we reviewed the inhaled long acting β2 agonist (LABA) indacaterol for chronic obstructive pulmonary disease (COPD). We concluded “There are no proven clinically meaningful benefits in terms of reduction in mortality or … Read More
Join the Conversation
NEW #UBC Therapeutics Initiative Letter 111:
Deprescribing Proton Pump Inhibitors:
ti.ubc.ca/letter111
#heartburn #deprescribing #ptsafety
Choosing Wisely Canada Canadian Association of Gastroenterology College of Pharmacists of BC deprescribing.org Canadian Deprescribing Network
[111] Deprescribing Proton Pump Inhibitors | Therapeutics Initiative
ti.ubc.ca
The first PPI was approved in Canada in 1988. Pronounced and durable reduction of stomach acid production made omeprazol...
